67 related articles for article (PubMed ID: 8913302)
1. Ligand-induced conformational change within the CD2 ectodomain accompanies receptor clustering: implication for molecular lattice formation.
Li J; Smolyar A; Sunder-Plassmann R; Reinherz EL
J Mol Biol; 1996 Oct; 263(2):209-26. PubMed ID: 8913302
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous regulation of CD2 adhesion and signaling functions by a novel CD2 monoclonal antibody.
van Kemenade FJ; Tellegen E; Maurice MM; Lankester AC; Kuijpers TW; Brouwer M; de Jong R; Miedema F; van Lier RA
J Immunol; 1994 May; 152(9):4425-32. PubMed ID: 7512595
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Cellular Avidity Regulation in CD2-CD58-Mediated T Cell Adhesion.
Zhu DM; Dustin ML; Cairo CW; Thatte HS; Golan DE
ACS Chem Biol; 2006 Nov; 1(10):649-58. PubMed ID: 17168569
[TBL] [Abstract][Full Text] [Related]
4. An anti-CD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligand-binding sites.
Kozarsky KF; Tsai C; Bott CM; Allada G; Li LL; Fox DA
Cell Immunol; 1993 Sep; 150(2):235-46. PubMed ID: 8103706
[TBL] [Abstract][Full Text] [Related]
5. Detection of a glycosylation-dependent ligand for the T lymphocyte cell adhesion molecule CD2 using a novel multimeric recombinant CD2-binding assay.
Parish CR; Recny MA; Knoppers MH; Waldron JC; Warren HS
J Immunol; 1993 Jun; 150(11):4833-43. PubMed ID: 7684413
[TBL] [Abstract][Full Text] [Related]
6. Identification of the TS2/18-recognized epitope on the CD2 molecule as a target for suppression of T cell cytokine synthesis.
Schwarz M; Bohuslav J; Majdic O; Stockinger H; Knapp W; Holter W
J Immunol; 1995 Jun; 154(11):5813-20. PubMed ID: 7538531
[TBL] [Abstract][Full Text] [Related]
7. A noncomitogenic CD2R monoclonal antibody induces apoptosis of activated T cells by a CD95/CD95-L-dependent pathway.
Fournel S; Robinet E; Bonnefoy-Bérard N; Assossou O; Flacher M; Waldmann H; Bismuth G; Revillard JP
J Immunol; 1998 May; 160(9):4313-21. PubMed ID: 9574534
[TBL] [Abstract][Full Text] [Related]
8. CD2 and TCR synergize for the activation of phospholipase Cgamma1/calcium pathway at the immunological synapse.
Espagnolle N; Depoil D; Zaru R; Demeur C; Champagne E; Guiraud M; Valitutti S
Int Immunol; 2007 Mar; 19(3):239-48. PubMed ID: 17220479
[TBL] [Abstract][Full Text] [Related]
9. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes: T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis.
Mollereau B; Blanchard D; Déas O; Dumont C; Métivier D; Bernard A; McGrew JT; Charpentier B; Vazquez A; Senik A
J Immunol; 1997 Sep; 159(6):2668-77. PubMed ID: 9300686
[TBL] [Abstract][Full Text] [Related]
10. Signaling via the CD2 receptor enhances HTLV-1 replication in T lymphocytes.
Guyot DJ; Newbound GC; Lairmore MD
Virology; 1997 Jul; 234(1):123-9. PubMed ID: 9234953
[TBL] [Abstract][Full Text] [Related]
11. Analysis of human and primate CD2 molecules by protein sequence and epitope mapping with anti-human CD2 antibodies.
Damschroder MM; Kozhich AA; Woods RM; Cheng L; Mullikin BA; Wilson SD; Ulbrandt ND; Bachy CM; Wu H; Suzich JA; Kiener PA; Dall'Acqua WF; White WI
Mol Immunol; 2004 Aug; 41(10):985-1000. PubMed ID: 15302161
[TBL] [Abstract][Full Text] [Related]
12. A novel, rapid and sensitive heterotypic cell adhesion assay for CD2-CD58 interaction, and its application for testing inhibitory peptides.
Liu J; Chow VT; Jois SD
J Immunol Methods; 2004 Aug; 291(1-2):39-49. PubMed ID: 15345303
[TBL] [Abstract][Full Text] [Related]
13. Impaired interleukin-2 synthesis and T cell proliferation following antibody-mediated CD3 and CD2 or CD28 cross-linking in trans: evidence that T cell activation requires the engagement of costimulatory molecules within the immunological synapse.
Watson CL; Furlong SJ; Hoskin DW
Immunol Invest; 2008; 37(1):63-78. PubMed ID: 18214800
[TBL] [Abstract][Full Text] [Related]
14. The receptor function of CD2 in human CD2 transgenic mice is based on highly conserved associations with signal transduction molecules.
Wild MK; Verhagen AM; Meuer SC; Schraven B
Cell Immunol; 1997 Sep; 180(2):168-75. PubMed ID: 9341747
[TBL] [Abstract][Full Text] [Related]
15. The CD2-subset of the Ig superfamily of cell surface molecules: receptor-ligand pairs expressed by NK cells and other immune cells.
Tangye SG; Phillips JH; Lanier LL
Semin Immunol; 2000 Apr; 12(2):149-57. PubMed ID: 10764623
[TBL] [Abstract][Full Text] [Related]
16. Measurement of T-cell CD69 expression: a rapid and efficient means to assess mitogen- or antigen-induced proliferative capacity in normals.
Mardiney M; Brown MR; Fleisher TA
Cytometry; 1996 Dec; 26(4):305-10. PubMed ID: 8979031
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms that set the stage for DC-T cell engagement.
van Gisbergen KP; Paessens LC; Geijtenbeek TB; van Kooyk Y
Immunol Lett; 2005 Mar; 97(2):199-208. PubMed ID: 15752559
[TBL] [Abstract][Full Text] [Related]
18. The biology of CD2: adhesion, transmembrane signal, and regulatory receptor of immunity.
Bromberg JS
J Surg Res; 1993 Mar; 54(3):258-67. PubMed ID: 8097269
[TBL] [Abstract][Full Text] [Related]
19. Molecular dissection of the CD2-CD58 counter-receptor interface identifies CD2 Tyr86 and CD58 Lys34 residues as the functional "hot spot".
Kim M; Sun ZY; Byron O; Campbell G; Wagner G; Wang J; Reinherz EL
J Mol Biol; 2001 Sep; 312(4):711-20. PubMed ID: 11575926
[TBL] [Abstract][Full Text] [Related]
20. Tumor therapy with bispecific antibody: the targeting and triggering steps can be separated employing a CD2-based strategy.
Wild MK; Strittmatter W; Matzku S; Schraven B; Meuer SC
J Immunol; 1999 Aug; 163(4):2064-72. PubMed ID: 10438945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
